Erratum to: "Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the diabetes prevention program" [Metabolism (2016) 65; 764-775].
Erratum to: "Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the diabetes prevention program" [Metabolism (2016) 65; 764-775].
复制标题
勘误:“脂联素的变化解释了生活方式干预引起的 HDL 颗粒的大部分变化,但不能解释糖尿病预防计划中的二甲双胍治疗”[Metabolism (2016) 65;
DOI:
10.1016/j.metabol.2016.11.007
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
DiabetesPreventionProgramResearchGroup
中科院分区:
文献类型:
--
作者:
Goldberg,RonaldB;Temprosa,Marinella;Mele,Lisa;Orchard,Trevor;Mather,Kieren;Bray,George;Horton,Edward;Kitabchi,Abbas;Krakoff,Jonathan;Marcovina,Santica;Perreault,Leigh;White,Neil;DiabetesPreventionProgramResearchGroup
Lipid-lowering meds (%) 4.9% 7.0% 4.0% 0.002 Triglyceride (mmol/L) 1.6 [1.1, 2.3] 1.6 [1.1, 2.2] 1.7 [1.2, 2.4]< 0.001 HDL-C (mmol/L) 1.1 [1.0, 1.3] 1.2 [1.0, 1.4] 1.0 [0.9, 1.2]< 0.001 Large HDL-P (μmol/L)⁎ 3.4 [2.2, 5.4] 4.2 [2.8, 6.1] 2.4 [1.7, 3.5]< 0.001 Medium HDL-P (μmol/L)⁎ 11 [8.1, 14.7] 12.3 [8.9, 16.5] 9.2 [6.5, 12]< 0.001 Small HDL-P (μmol/L)⁎ 19.1 [16.1, 22.3] 18.5 [15.4, 21.9] 20.1 [17.3, 22.9]< 0.001 Total HDL-P (μmol/L)⁎ 34.4 [30.8, 38.8] 35.9 [32.0, 40.2] 32.3 [29.1, 35.5]< 0.001 HDL size (nm)⁎ 8.8 [8.6, 9.1] 8.8 [8.7, 9.2 8.6 [8.5, 8.8]< 0.001 Adiponectin (ng/ml) 7.3 [1.7, 7.6] 7.8 [6.0, 10.3] 6.3 [4.9, 8.0]< 0.001 tPA (ng/ml) 10.9 [8.7, 13.4] 10.4 [8.3, 12.7] 12.0 [9.9, 14.6]< 0.001 Fibrinogen (mg/dL) 374.0 [328.0, 432.0] 388.0 [340.0, 448.0] 348.0 [307.0, 397.0]< 0.001 CRP (mg/L) 3.7 [1.7, 7.6] 5.0 [2.5, 9.2] 2.0 [0.9, 3.8]< 0.001 IL6 (pg/ml) 1.9 [1.3, 3.0] 2.1 [1.4, 3.2] 1.6 [1.1, 2.5]< 0.001 MCP1 (pg/ml) 138.0 [115.7, 167.1] 135.3 [113.2, 165.4] 143.7 [121.0, 169.6]< 0.001 sICAM (ng/ml) 247.0 [209.6, 288.8] 251.4 [212.0, 293.4] 239.8 [203.6, 278.3]< 0.001 sE selectin (ng/ml) 44.0 [32.9, 56.7] 43.7 [32.3, 56.2] 44.5 [34.2, 57.7] 0.046